FQI1

FQI1 is a Late SV40 Factor (LSF) inhibitor. FQI1 inhibits cell proliferation, with IC50s of 3, 0.79, 6.3 μM for NIH/3T3, HeLa, A549 cells. FQI1 can be used for cancer research[1].

Product Specifications

CAS Number

[599151-35-6]

UNSPSC

12352005

Hazard Statement

H301, H400

Target

ERK

Type

Reference compound

Related Pathways

MAPK/ERK Pathway; Stem Cell/Wnt

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/fqi1.html

Purity

99.11

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C1NC2=C(C=C3C(OCO3)=C2)C(C4=CC=CC=C4OCC)C1

Molecular Formula

C18H17NO4

Molecular Weight

311.33

Precautions

H301, H400

References & Citations

[1]Ulla Hansen, et al. Inhibitors of late sv40 factor (lsf) as cancer chemotherapeutics. WO2012050985.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

TA809863AM 100 µL

USP40 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI4F7]

Ask

View Details

MBS1075679-01 0.05 mg (E-Coli)

Recombinant Human Urine glycopeptide, partial

Ask

View Details

MBS1075679-02 0.2 mg (E-Coli)

Recombinant Human Urine glycopeptide, partial

Ask

View Details

MBS1075679-03 0.5 mg (E-Coli)

Recombinant Human Urine glycopeptide, partial

Ask

View Details

MBS1075679-04 0.05 mg (Baculovirus)

Recombinant Human Urine glycopeptide, partial

Ask

View Details

MBS1075679-05 0.2 mg (Yeast)

Recombinant Human Urine glycopeptide, partial

Ask

View Details